AI assistant
Sending…
Cidara Therapeutics, Inc. — Director's Dealing 2021
Sep 3, 2021
31535_dirs_2021-09-03_17c7f7cb-cd41-4172-a9dd-99416d0b1366.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-09-01
Reporting Person: Shah Preetam (CFO & CBO)
More from Cidara Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 12
Regulatory Filings
2026
Jan 12
Regulatory Filings
2026
Jan 12
Regulatory Filings
2026
Jan 12
Regulatory Filings
2026
Jan 12
Regulatory Filings
2026
Jan 12